CRP and cancer: Specificity was 45.9% (95% CI 44.7–47.1), compared to 90.0% for FIT alone (in the subset with serum ferritin and CRP), leading to one cancer in every 57 positive tests compared to one in 12 in the FIT-only approach (Table 3, Additional file 1: Table S2).